Showing 18,461 - 18,480 results of 103,867 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.17s Refine Results
  1. 18461
  2. 18462

    Representation and kinetics of conservative oscillators based on motif 2 and motif 5. by Kristian Thorsen (631743)

    Published 2014
    “…(c) , , and frequency as a function of the perturbation . While the frequency increases and decreases with increasing , is kept at its set-point . …”
  3. 18463

    DataSheet1_Clinical Effectiveness of Conservative Treatments on Lumbar Spinal Stenosis: A Network Meta-Analysis.docx by Xuanwei Chen (10004107)

    Published 2022
    “…Meanwhile, limaprost combined with analgesics drugs was found to be effective to improve the EuroQol Five Dimensions Questionnaire.</p><p>Conclusion: Among the commonly used conservative treatments for the treatment of lumbar spinal stenosis, limaprost may have better efficacy in improving the Japanese Orthopaedic Association Score and decreasing the Oswestry Dysfunction Index, with a beneficial effect on decreasing the visual analog scale and improving the EuroQol Five Dimensions Questionnaire.…”
  4. 18464

    Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells by Magdalena Circu (4458754)

    Published 2017
    “…Cell viability of cisplatin-treated A549cisR cells was decreased when co-treated with chloroquine, corresponding to a combination index below 0.8, suggesting synergism between the two drugs. …”
  5. 18465

    The expression of Atpv1c1 was efficiently knocked down by AAV-sh-<i>Atp6v1c1</i>. by Sheng Li (107261)

    Published 2015
    “…<p>(A-G) M-CSF/RANKL was applied for 3 days to allow differentiation of osteoclasts, which were then transduced with AAV-sh-Atp6v1c1, AAV-sh-luc-YFP, or untreated (mock). …”
  6. 18466

    Spleen cell phenotype in NZW/BXSB<sup>TLR7-/Yaa</sup> mice (n = 10) and WT littermates (n = 5): A: T cell, B cell and dendritic cell percentages.... by Alexis Boneparth (707054)

    Published 2015
    “…<p>Spleen cell phenotype in NZW/BXSB<sup>TLR7-/Yaa</sup> mice (n = 10) and WT littermates (n = 5): A: T cell, B cell and dendritic cell percentages. …”
  7. 18467

    Cytochrome P450 3A activity and protein expression in cirrhosis and normal liver tissue samples. by Raj Vuppalanchi (458660)

    Published 2013
    “…<p>(<b>A</b>) Decreased CYP3A activity as determined by the intrinsic clearance based on formation of 1’-OH midazolam formation in cirrhosis and normal liver tissue samples. …”
  8. 18468
  9. 18469
  10. 18470

    Comparative Transcriptome Analysis between the Cytoplasmic Male Sterile Line NJCMS1A and Its Maintainer NJCMS1B in Soybean (<i>Glycine max</i> (L.) Merr.) by Jiajia Li (184267)

    Published 2015
    “…Three hundred and sixty five differentially expressed genes (DEGs) between NJCMS1A and NJCMS1B were screened by threshold, among which, 339 down-regulated and 26 up-regulated in NJCMS1A compared to in NJCMS1B. …”
  11. 18471
  12. 18472
  13. 18473

    Trichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway by Li-Fu Li (84336)

    Published 2017
    “…</p><p>Methods</p><p>Five days after bleomycin treatment to mimic acute lung injury (ALI), wild-type or Akt-deficient C57BL/6 mice were exposed to low-tidal-volume (low-V<sub>T</sub>, 6 mL/kg) or high-V<sub>T</sub> (30 mL/kg) MV with room air for 5 h after receiving 2 mg/kg TSA. …”
  14. 18474

    Representative sets of <i>K</i><sup><i>trans</i></sup> maps (A) from five different experiments before and after Cilengitide treatment in each set. by Tavarekere N. Nagaraja (501546)

    Published 2013
    “…Representative sets of <i>v</i><sub><i>e</i></sub> maps from the same five experiments before and after Cilengitide treatment in each set are shown in B. …”
  15. 18475
  16. 18476
  17. 18477

    Morphology and cell viability in U-87MG, U-251MG, SHSY5Y and N2a cells after treatment with SLCP, BBR and SLCP+BBR. by Panchanan Maiti (1459852)

    Published 2019
    “…<b>D-E:</b> Cell viability was unaltered in the case of N2a (D) and SH-SY5Y cells after 24-h of SLCP and or BBR, although co-treatment caused a 40% increase in cell death in SH-SY5Y cells (<b>E</b>). …”
  18. 18478

    Modeling ENSO impact on rice production in the Mekong River Delta by Bui Tan Yen (7526093)

    Published 2019
    “…The autumn-winter crop would decrease by 331,480 tons under RCP4.5 and 462,720 tons under RCP8.5. …”
  19. 18479

    Image_1_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”
  20. 18480

    Image_2_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”